Vijayanagar 4th Stage, Outer Ring Road, Mysuru Mon–Sat, 8:30 AM – 6:30 PM 90 minutes from Bengaluru on the expressway

IVF & assisted reproduction

IVF after 35: what changes and what should you know?

By Ms. Aanchal Saini · 17 min read · Published

Navigating Fertility in Your Late Thirties

Planning family building in your mid-to-late thirties is common in modern life. While obstetric care has made pregnancy at this age safe, ovarian biology follows predetermined timelines.

A woman is born with her entire lifetime supply of oocytes. By age 35, both oocyte quantity (ovarian reserve) and oocyte quality (chromosomal integrity) undergo progressive changes.

The Science of Egg Aging: Quantity vs Quality

  • Oocyte Quantity: Measured via serum AMH and Antral Follicle Count (AFC). Indicates how many eggs can be retrieved in a stimulation cycle.
  • Oocyte Quality: Driven primarily by maternal chronological age. Dictates the percentage of embryos that are chromosomally normal (euploid).
  • At age 30, ~70% of embryos are euploid.
  • At age 35–37, ~50% to 55% of embryos are euploid.
  • At age 38–39, ~35% to 45% of embryos are euploid.

Clinical Strategies for IVF Success After 35

  • Dual-Action Stimulation (FSH + LH / hMG): Supports granulosa cell androgen receptors, optimizing follicle recruitment.
  • Day-5 Blastocyst Culture: Culturing past Day 3 allows embryos to activate their own embryonic genome, filtering out non-viable embryos.
  • Selective PGT-A: Biopsying trophectoderm cells to identify chromosomally normal blastocysts prior to transfer.
  • Freeze-All Strategy: Allowing hormonal levels to normalize before transfer in a prepared cycle.

Frequently asked questions

No. AMH reflects egg quantity (how many follicles respond to stimulation), but egg chromosomal normalcy is primarily determined by age.

Medical references and standards: This content follows clinical guidance from the American Society for Reproductive Medicine, the European Society of Human Reproduction and Embryology, and the Assisted Reproductive Technology (Regulation) Act, 2021. It is written for patient education and does not replace individual medical advice or diagnosis.